Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2011

The following table is an aging of the Company’s December 31, 2011 and 2010 gross accounts receivable (net of allowances for contractual adjustments, and prior to allowances for doubtful accounts), aged based on payment terms and categorized based on the four primary overall types of accounts receivable characteristics (in thousands):



December 31, 2011	Current and 0-180 Days Past Due		181 Days and Over Past Due		Total
Medicare (Part D and Part B), Medicaid
and Third-Party payors	$	257,782	$	199,303	$	457,085
Facility payors	387,509		204,419		591,928
Private Pay payors	85,934		155,080		241,014
Total gross accounts receivable (net of contractual allowance adjustments)	$	731,225	$	558,802	$	1,290,027
December 31, 2010
Medicare (Part D and Part B), Medicaid
and Third-Party payors	$	260,788	$	185,934	$	446,722
Facility payors	389,887		312,996		702,883
Private Pay payors	96,047		167,198		263,245
Total gross accounts receivable (net of contractual allowance adjustments)	$	746,722	$	666,128	$	1,412,850

Financial assets and liabilities measured at fair value

The Company’s assets and (liabilities) measured at fair value were as follows (in thousands):



				Based on
	Fair Value			Quoted Prices in Active Markets (Level 1)		Other Observable Inputs (Level 2)			Unobservable Inputs (Level 3)
December 31, 2011
Assets and (Liabilities) Measured at Fair Value on a Recurring Basis:
7.75% interest rate swap agreement - fair value hedge ⁽¹⁾	$	35,473		$	—	$	35,473		$	—
Derivatives ⁽²⁾	—			—		—			—
Total	$	35,473		$	—	$	35,473		$	—

December 31, 2010
Assets and (Liabilities) Measured at Fair Value on a Recurring Basis:
Rabbi trust assets ⁽³⁾	$	85,741		$	85,741	$	—		$	—
7.75% interest rate swap agreement - fair value hedge ⁽¹⁾	$	(829	)	$	—	$	(829	)	$	—
6.875% interest rate swap agreement - fair value hedge ⁽¹⁾	(3,461		)	—		(3,461		)	—
Derivatives ⁽²⁾	—			—		—			—
Total	$	(4,290	)	$	—	$	(4,290	)	$	—

Accumulated other comprehensive income(loss)

Accumulated other comprehensive income (loss) consists of the following (in thousands):



	December 31,
	2011			2010
Cumulative foreign currency translation adjustments	$	10,548		$	15,239
Translation adjustment recorded as loss on the sale of CRO	(2,210		)	—
Unrealized gain (loss) on fair value of investments	(277		)	997
Pension and postemployment benefits	(1,029		)	(1,022		)
Total accumulated other comprehensive income (loss), net	$	7,032		$	15,214

Sales as a Percent by Payor [Table Text Block]

The table below represents the Company’s approximated payor mix (as a % of annual sales) for the last three years ended December 31,:



	2011		2010		2009
Private pay, third-party and facilities ^(a)	41	%	42	%	43	%
Federal Medicare program (Part D & Part B)	47	%	46	%	45	%
State Medicaid programs	9	%	9	%	10	%
Other sources	3	%	3	%	2	%
Totals	100	%	100	%	100	%

Schedule of Other Operating Cost and Expense, by Component [Table Text Block]

Other Miscellaneous Charges consist of the following (in thousands):



	December 31,
	2011				2010			2009
Acquisition and other related costs⁽¹⁾	$	25,549			$	5,319		$	1,399
Restructuring and other related charges ⁽²⁾	—				17,165			19,814
Stock option expense ⁽³⁾	—				4,207			5,633
Repack matters - SG&A⁽⁴⁾	(10,500		)		663			1,503
Asset impairment charges ⁽⁵⁾	—			—	22,884			—
Separation, benefit plan termination and related costs ⁽⁶⁾	1,044				64,760			—
Loss on plane lease ⁽⁷⁾	—				6,785			—
Debt redemption loss and costs⁽⁸⁾	—				27,346			—
Subtotal - other miscellaneous charges	16,093				149,129			28,349
Repack matters - COS⁽⁴⁾	—				(1,898		)	(2,642		)
Total - other miscellaneous charges, net	$	16,093			$	147,231		$	25,707


(1)	See further discussion at the “Acquisitions” note of the Notes to Consolidated Financial Statements.


(2)	See further discussion at the "Restructuring and Other Related Charges" note of the Notes to Consolidated Financial Statements.


(3)	See further discussion at the “Stock-Based Compensation” note of the Notes to Consolidated Financial Statements.


(4)	See further discussion at the “Commitments and Contingencies” note of the Notes to Consolidated Financial Statements.


(5)	See additional information at the "Goodwill and Other Intangible Assets" note of the Notes to Consolidated Financial Statements.


(6)	See additional information at the "Separation, Benefit Plan Termination and Related Costs" note of the Notes to Consolidated Financial Statements.


(7)	The year ended December 31, 2010 includes a charge relating to the termination of the Company’s prior aircraft lease.


(8)	See further discussion at the “Debt” note of the Notes to Consolidated Financial Statements.

- Definition

Tabular disclosure of the fair value measurement of assets and liabilities which includes [financial] instruments measured at fair value that are classified in stockholders' equity. Such assets and liabilities may be measured on a recurring or nonrecurring basis. The disclosures which may be required or desired include: (1) for assets and liabilities measured on a recurring basis, disclosure may include: (a) the fair value measurements at the reporting date; (b) the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3); (c) for fair value measurements using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (i) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (ii) purchases, sales, issuances, and settlements (net); (iii) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs); (d) the amount of the total gains or losses for the period in subparagraph (c) (i) above included in earnings (or changes in net assets) that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date and a description of where those unrealized gains or losses are reported in the statement of income (or activities); (e) the valuation technique(s) used to measure fair value and a discussion of changes in valuation techniques, if any, during the period and (2) for assets and liabilities that are measured at fair value on a nonrecurring basis (for example, impaired assets) disclosure may include, in addition to (a) above: (a) the reasons for the fair value measurements recorded; (b) the same as (b) above; (c) for fair value measurements using significant unobservable inputs (Level 3), a description of the inputs and the information used to develop the inputs; and (d) the valuation technique(s) used to measure fair value and a discussion of changes, if any, in the valuation technique(s) used to measure similar assets and/or liabilities in prior periods. Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19279-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 157

-Paragraph 32

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 157

-Paragraph 33

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 107

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19296-110258

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19207-110258

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 157

-Paragraph 6

-Footnote 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19190-110258

+ Details